Literature DB >> 4646726

Pupillary constriction after marijuana smoking.

R S Hepler, I M Frank, J T Ungerleider.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4646726     DOI： 10.1016/0002-9394(72)90741-6

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  9 in total

Review 1.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

2.  Microbiological transformations of nabilone, a synthetic cannabinoid.

Authors:  R A Archer; D S Fukuda; A D Kossoy; B J Abbott
Journal:  Appl Environ Microbiol       Date:  1979-05       Impact factor: 4.792

Review 3.  Nabilone. A preliminary review of its pharmacological properties and therapeutic use.

Authors:  A Ward; B Holmes
Journal:  Drugs       Date:  1985-08       Impact factor: 9.546

Review 4.  Biomarkers for the effects of cannabis and THC in healthy volunteers.

Authors:  Lineke Zuurman; Annelies E Ippel; Eduard Moin; Joop M A van Gerven
Journal:  Br J Clin Pharmacol       Date:  2009-01       Impact factor: 4.335

5.  Delta-9-tetrahydrocannabinol (THC) in the treatment of end-stage open-angle glaucoma.

Authors:  Allan J Flach
Journal:  Trans Am Ophthalmol Soc       Date:  2002

6.  Unilateral angle-closure glaucoma with ciliochoroidal effusion after the consumption of cannabis: a case report.

Authors:  Rana Hanna; Beatrice Tiosano; Noora Dbayat; Dan Gaton
Journal:  Case Rep Ophthalmol       Date:  2014-12-10

Review 7.  Eyeing up the Future of the Pupillary Light Reflex in Neurodiagnostics.

Authors:  Charlotte A Hall; Robert P Chilcott
Journal:  Diagnostics (Basel)       Date:  2018-03-13

Review 8.  Considerations for Cannabinoids in Perioperative Care by Anesthesiologists.

Authors:  Krzysztof Laudanski; Justin Wain
Journal:  J Clin Med       Date:  2022-01-22       Impact factor: 4.241

9.  THC Regulates Tearing via Cannabinoid CB1 Receptors.

Authors:  Amanda Thayer; Natalia Murataeva; Vanessa Delcroix; Jim Wager-Miller; Helen P Makarenkova; Alex Straiker
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-08-03       Impact factor: 4.799
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.